To view this email as a web page, click here.

Biopsies May Help Guide Treatment for Bladder Cancer

A new study found a biopsy of a single metastasis may be enough to help oncologists tailor a treatment that targets all of a patient’s tumors.

Cost Effectiveness of CAR T-Cell Therapy Depends on Long-Term Outcomes

Researchers conducted a cost-effectiveness analysis on the two FDA-approved CAR T-cell therapies for diffuse large B-cell lymphoma.

IN CASE YOU MISSED IT

Could Gait Speed Predict Outcomes in Older Patients With Blood Cancers?

The gait speed of an older patient with a hematologic malignancy may be an indicator of that patient’s frailty and could predict for worse clinical outcomes.

Read more

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.